AI in Health Advertising: The Regulatory Storm Coming in 2026

Colorado's AI Law: The First Shot Across the Bow

In 2024, Colorado became the first state to pass comprehensive AI legislation. The law doesn't take effect until June 30, 2026—but that's less than two years away. And when it does, it will fundamentally change how audience vendors can operate in healthcare advertising.

The law specifically targets what it calls "high-risk AI systems"—algorithms that influence what it defines as "consequential decisions." And here's the kicker: Healthcare is explicitly on that list.

If an algorithm decides who gets an ad for a hospital, treatment, or medical service, Colorado considers that an algorithm influencing access to care. That makes it high-risk AI. Which means it triggers a cascade of compliance requirements that most vendors can't—or won't—meet.

What Most Audience Vendors Do (And Why It's Now a Problem)

Let's be clear about what's standard practice in healthcare audience targeting today:

Prediction Models

Most vendors use machine learning to predict who "looks like" a patient. They take known behaviors and demographics, run them through an algorithm, and output a probability score. This person has a 73% likelihood of needing orthopedic care. That person is 62% likely to be diabetic.

Propensity Scores

Vendors assign propensity scores to individuals—numerical values indicating how likely someone is to have a condition, need a treatment, or respond to an ad. These scores are the foundation of "likely condition" segments.

"Likely Condition" Segments

The end product is audience segments marketed as "likely diabetics," "probable cardiovascular patients," or "high propensity orthopedic prospects." These segments are sold to healthcare marketers as turnkey solutions for patient acquisition.

All of this has been common practice. But under Colorado's AI law—and the laws that will inevitably follow—it's about to become a massive compliance problem.

Why This Is "High-Risk AI" Under Colorado's Law

Colorado defines high-risk AI as systems that make or substantially influence "consequential decisions." The law includes a specific list of consequential decision categories—and healthcare is front and center.

Here's the logic: If an algorithm determines who sees an ad for cancer screening, orthopedic surgery, or diabetes management, it's influencing access to healthcare services. It's deciding who gets awareness of potentially life-saving treatments and who doesn't.

That makes it a consequential decision. Which makes the AI system high-risk. Which triggers a laundry list of compliance requirements:

• Impact assessments: Detailed documentation of the system's purpose, data sources, and risks
• Bias testing: Regular audits to detect and mitigate algorithmic discrimination
• Ongoing monitoring: Continuous evaluation of the system's performance and fairness
• Transparency disclosures: Clear communication about how the AI system works and makes decisions
• Risk management programs: Formal processes to identify and mitigate potential harms
• Record keeping: Extensive documentation for regulatory review

For most audience vendors, this is an operational nightmare. Many don't have the infrastructure, expertise, or transparency to comply. And even if they did, the cost would be prohibitive.

Colorado Isn't Alone: The AI Regulation Wave Is Here

Colorado was first, but it won't be the last. AI regulation is accelerating across the country:

States That Have Passed AI Laws

• Colorado: Comprehensive AI regulation effective June 30, 2026
• California: Multiple AI bills addressing transparency and risk management
• Utah: AI regulations focused on consumer protection
• Texas: AI disclosure requirements for certain sectors

States with AI Bills in the Pipeline

Nine additional states have active AI legislation under consideration. The trend is clear: Regulation is coming, and it's coming fast. Healthcare advertising—already heavily regulated under privacy laws—is a prime target.

By 2027, healthcare marketers operating nationally will likely face a patchwork of AI regulations similar to today's state privacy laws. Except this time, the focus won't just be on consent—it will be on algorithmic transparency, bias, and fairness.

Most Vendors Aren't Ready (And They Know It)

Here's what's remarkable: Despite these looming regulations, most audience vendors are still touting AI as a selling point. Marketing materials emphasize "AI-powered targeting," "machine learning models," and "predictive analytics" as if there are no regulatory concerns at all.

But behind the scenes, the reality is different. Many vendors are:

• Operating black-box models with no visibility into how predictions are made
• Unable to explain why someone received a particular propensity score
• Lacking bias testing infrastructure or methodologies
• Unwilling to disclose data sources or model inputs
• Ignoring the regulatory landscape until enforcement forces their hand

This isn't sustainable. When Colorado's law takes effect, and other states follow, healthcare marketers using these vendors will face significant risk. The liability won't just fall on vendors—it will extend to the brands using their audiences.

How Blueprint Built Differently: No AI Black Boxes

At Blueprint Audiences, we saw this coming. We didn't wait for regulators to force change—we built our entire platform around a different philosophy from day one.

No Prediction Models

We don't predict who "looks like" a patient. We don't use machine learning to infer health conditions. We don't assign propensity scores based on algorithmic guesswork. Instead, we use explicit signals—observable behaviors, declared interests, and contextual data—to build audiences.

No AI Black Boxes

Every Blueprint audience is fully transparent. We can explain exactly how it was built, what data sources were used, and why someone qualified for inclusion. There are no opaque algorithms making consequential decisions about who sees healthcare ads.

Precise, Compliant Audiences

Our approach delivers precision without prediction. We reach the right people—those actively seeking care, engaging with relevant content, or expressing clear health interests—without relying on AI inference. This keeps our audiences compliant not just with privacy laws, but with the AI regulations that are coming.

We built Blueprint for the privacy era. And now, as AI regulations emerge, we're already compliant. Because we never relied on the risky practices that regulators are targeting.

What Healthcare Marketers Should Do Now

If you're a healthcare marketer using audience vendors, here's what you need to do before June 2026:

1. Audit Your Current Vendors

Ask direct questions: Do they use AI or machine learning in audience construction? Can they explain how their models work? Have they conducted bias testing? Are they preparing for Colorado's AI law?

2. Understand Your Risk Exposure

If your vendors use predictive models to build "likely condition" segments, you're exposed. Under Colorado's law, you may share liability for using high-risk AI systems. Document your vendor relationships and evaluate whether they meet emerging regulatory standards.

3. Demand Transparency

Black-box audiences are no longer defensible. You need to know exactly how your audiences are built, what data sources are used, and whether AI is involved. If your vendor can't or won't provide that transparency, it's time to reconsider the relationship.

4. Transition to Compliant Solutions

Start moving toward audience vendors that don't rely on AI prediction models. Look for partners who build audiences on explicit signals, observable behaviors, and transparent methodologies. The transition takes time—don't wait until enforcement begins.

The regulatory landscape is changing. Marketers who adapt proactively will be positioned for success. Those who wait will face disruption, compliance costs, and potential liability.

The Bigger Picture: AI Isn't Going Away, But How We Use It Must Change

This isn't about demonizing AI. Artificial intelligence has tremendous potential to improve healthcare marketing, patient engagement, and health outcomes. But like any powerful technology, it needs guardrails.

Colorado's law—and the regulations that will follow—are those guardrails. They're asking a simple but important question: Should opaque algorithms be making decisions about who sees healthcare advertising? Should we accept systems that we can't explain, audit, or hold accountable?

The answer, increasingly, is no. Not because AI is inherently bad, but because the stakes in healthcare are too high for unaccountable systems. Access to care, health equity, and patient safety all depend on fair, transparent advertising practices.

The vendors who succeed in this new era will be those who embrace transparency, reject black-box models, and build audiences that can withstand regulatory scrutiny. That's the future of healthcare advertising. And at Blueprint, that's what we've built from the start.

Key Takeaways: The AI Regulation Era Is Here

• Colorado's AI law takes effect June 30, 2026 — targeting prediction models and propensity scoring in healthcare advertising
• Most vendors use high-risk AI — machine learning models that predict health conditions and assign propensity scores
• This triggers compliance requirements — bias testing, impact assessments, transparency disclosures, and ongoing monitoring
• More states are following Colorado's lead — California, Utah, Texas have passed AI laws; nine more have bills in the pipeline
• Most vendors aren't ready — they're still touting AI as a feature while ignoring regulatory risks
• Blueprint built differently — no prediction models, no AI black boxes, just transparent, compliant audiences
• Marketers need to act now — audit vendors, demand transparency, and transition to compliant solutions before enforcement begins